Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120

AIDS

Volumn 10, Issue 5, 1996, Pages 463-468

  Pittaluga, Anna ^a   Pattarini, Roberto ^a   Severi, Paolo ^b   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GALLIERA HOSPITAL   (Italy)

Author keywords

Envelope proteins; Glutamate receptors; gp120; gp120 V3 loop; Human brain neocortex; Memantine; N methyl D aspartate receptors; Noradrenaline release; Noradrenergic neurons

Indexed keywords

7 CHLOROKYNURENIC ACID; COAT PROTEIN; DIZOCILPINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MALE; NEOCORTEX; NERVE ENDING; NEUROTRANSMITTER RELEASE; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYNAPTOSOME;

EID: 0029988309     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199605000-00003     Document Type: Article

References (42)

1. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
2. Lipton SA: Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 1992, 15:75-79.
3. 2+, N-methyl-D-aspartate receptors, and AIDS-related neuronal injury. Int Rev Neurobiol 1994, 36:1-27.
4. Spencer DC, Price RW: Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol 1992, 46:655-693.
5. Brennemann DE, Westbrook GL, Fitzgerald SP, et al.: Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988, 335:639-642.
6. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA: HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 1990, 248:364-367.
7. Müller WEG, Schröder HC, Ushijima H, Dapper J, Bormann J: gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol Mol Pharmacol Sect 1992, 226:209-214.
8. Dawson VL, Dawson TM, Uhl GR, Snyder SH: Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 1993, 90:3256-3259.
9. Savio T, Levi G: Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res 1993, 34:265-272.
10. Ushijima H, Nishio O, Klöcking R, Perovic S, Müller WEG: Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur J Neurosci 1995, 7:1353-1359.
11. Giulian D, Vaca K, Noonan CA: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990, 250:1595-1596.
12. Benos DJ, Hahn BH, Nubien JK, et al.: Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994, 91:494-498.
13. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L: Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994, 338:638-641.
14. Bagetta G, Finazzi Agrò A, Palma E, Nisticò; G: Intracerebral injection of human immunodeficiency virus type I coat glycoprotein gp120 does not produce neurodegeneration in rats. Neurosci Lett 1994, 176:97-100.
15. Levi G, Patrizio M, Bernardo A, Petrucci TC, Agresti C: Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci USA 1993, 90:1541-1545.
16. i responses not only in type-2 but also type-1 astrocytes and oligodendrocytes of the rat cerebellum. Eur /J Neurosci 1995, 7:1333-1341.
17. Pittaluga A, Raiteri M: HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings. Eur J Neurosci 1994, 6:1743-1749.
18. Fink K, Schultheiss R, Göthert M: Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors. Br J Pharmacol 1992, 106:67-72.
19. Collingridge GL, Bliss TVP: NMDA receptors: their role in long-term potentiation. Trends Neurosci 1987, 10:288-293.
20. Cahill L, Prins B, Weber M, McGaugh JL: Beta-adrenergic activation and memory for emotional events. Nature 1994, 371:702-704.
21. 2-autoreceptors in human brain cortex. Br J Pharmacol 1992, 107:1146-1151.
22. β-type in human cerebral cortex. Br J Pharmacol 1989, 96:341-346.
23. Raiteri M, Angelini F, Levi G: A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 1974, 25:411-414.
24. Johnson JW, Asther P: Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325:529-531.
25. Kemp JA, Foster AC, Leeson PD, et al.: 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci USA 1988, 85:6547-6550.
26. 3H]norepinephrine release is modulated by glycine. Eur J Pharmacol 1988, 156:149-155.
27. Woodward JJ: A comparison of the effects of ethanol and the competitive glycine antagonist 7-chlorokynurenic acid on N-methyl-D-aspartic acid-induced neurotransmitter release from rat hippocampal slices. J Neurochem 1994, 62:987-991.
28. Pittaluga A, Pattarini R, Raiteri M: Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. Eur J Pharmacol 1995, 272:203-209.
29. LaRosa GJ, Davide JP, Weinhold K, et al.: Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 1990, 249:932-935.
30. Lasky LA, Nakamura G, Smith DH, et al.: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987, 50:975-985.
31. Raiteri M, Marchi M, Maura G: Release of catecholamines, serotonin, and acetylcholine from isolated brain tissue. In Handbook of Neurochemistry. Edited by Lajtha A. New York: Plenum Publishing, 1984:431-462.
32. Harouse JM, Bhat S, Spitalnik SL, et al.: Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991, 253:320-323.
33. Cook DG, Fantini J, Spitalnik SL, Gonzalez-Scarano F: Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology 1994, 201:206-214.
34. Schell MJ, Molliver ML, Snyder SH: D-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 1995, 92:3948-3952.
35. Funke I, Hahn A, Rieber HP, Weiss E, Riethmüller G: The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. J Exp Med 1987, 165:1250-1255.
36. Skinner MA, Langlois AJ, McDanal CB, McDougal JS, Bolognesi DP, Matthews TJ: Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J Virol 1988, 62:4195-4200.
37. 3H]Glycine uptake in rat hippocampus: kinetic analysis and autoradiographic localization. Brain Res 1992, 572:154-165.
38. McGaugh J: Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 1989, 12:255-287.
39. Hasselmo MF, Bower JM: Acetylcholine and memory. Trends Neurosci 1995, 16:218-222.
40. Glowa JR, Panlilio LV, Brennemann DE, Gozes I, Fridkin M, Hill JM: Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 1992, 570:49-55.
41. Bormann J: Memanline is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channel. Eur J Pharmacol 1989, 166:591-592.
42. Schneider E, Fischer PA, Clemens R, Balzereit F, Füngfeld E-W, Haase H-J: Wirkungen oraler Mementin-Gaben auf die Parkinson-Symptomatik. Dtsch Med Woschenschr 1984, 109:987-990.